stage III colorectal cancer

You have access
Poor Prognosis in Patients With Stage III Colorectal Cancer Receiving Adjuvant FOLFOX/CAPOX Therapy Is Predicted by the Presence of Many Poorly Differentiated Clusters
KAZUHIKO YOSHIMATSU, TEPPEI KONO, MASAYA SATAKE, YOSHITOMO ITO, SHUNICHI SHIOZAWA, HIRONORI TANAKA, MASAHARU HIGASHIDA, TOSHIMASA OKADA, SHUJI ENDO, YOSHINAORI FUJIWARA and TOMIO UENO

Anticancer Research July 2023, 43 (7) 3235-3240; DOI: https://doi.org/10.21873/anticanres.16497
You have access
Effect of Adjuvant Chemotherapy on Survival of Elderly Patients With Stage III Colorectal Cancer
MASATSUNE SHIBUTANI, KIYOSHI MAEDA, SHINICHIRO KASHIWAGI, KOSEI HIRAKAWA and MASAICHI OHIRA

Anticancer Research July 2021, 41 (7) 3615-3624; DOI: https://doi.org/10.21873/anticanres.15150
You have access
Prognostic Markers in Early-stage Colorectal Cancer: Significance of TYMS mRNA Expression
ANNA KOUMARIANOU, IOANNA TZEVELEKI, DIMOSTHENIS MEKRAS, ANASTASIA G. ELEFTHERAKI, MATTHEOS BOBOS, RALPH WIRTZ, ELENA FOUNTZILAS, CHRISTOS VALAVANIS, IOANNIS XANTHAKIS, KONSTANTINE T. KALOGERAS, GEORGE BASDANIS, GEORGE PENTHEROUDAKIS, VASSILIKI KOTOULA and GEORGE FOUNTZILAS

Anticancer Research September 2014, 34 (9) 4949-4962;

Main menu